The duty of care: a genetic balancing act?
Genetic testing is becoming a standard part of UK healthcare, with plans to expand its use. But who does this information belong to, and who decides who it is shared with?
Careers | Find us | Contact us
2021-10-10T11:00:14+01:0019 March 2020|
Genetic testing is becoming a standard part of UK healthcare, with plans to expand its use. But who does this information belong to, and who decides who it is shared with?
2019-01-17T10:39:34+00:0017 January 2019|
Sarion Bowers, Policy Lead at the Sanger Institute, reflects on how Brexit will affect science.
2018-12-20T13:34:11+00:0020 December 2018|
Hayley Clissold from the Sanger Institute's policy team team explores the issues surrounding gene editing and human embryos
2018-12-11T15:35:35+00:0011 December 2018|
Evidence is a vital part of policy-making - but it's by no means the only part. We look at how scientists can get involved and make a difference.
2018-12-06T11:57:43+00:006 December 2018|
Our Policy Lead, Sarion Bowers, explores the extraordinary claims that the world’s first genome edited babies have been born.
2018-11-29T15:35:59+00:0029 November 2018|
Anna Middleton, Head of the Society and Ethics research group at Wellcome Genome Campus Connecting Science, reports on Prof He Jiankiu's unverified announcement of gene editing the first human embryos that have been born
2018-11-09T08:00:43+00:009 November 2018|
The idea that we should benefit from scientific advancement is something we may never have thought of as human right, yet the Universal Declaration of Human Rights firmly makes the case that it is everyone's right, regardless of education, wealth or background, explains Sarion Bowers
2018-06-20T09:31:24+01:0020 June 2018|
Now is the time for scientists to strike a deal everyone that benefits society as well as research, argue Anna Middleton, Vivienne Parry and Julian Borra
2017-08-03T16:05:37+01:003 August 2017|
03.08.17 This week the American Society of Human Genetics issued a policy on the application of germline editing – the ability to alter the genetic makeup of early stage embryos. Anna Middleton, one of the contributors to the statement, explains the policy's position
Wellcome Genome Campus,
Hinxton, Cambridgeshire,
CB10 1SA. UK
+44 (0)1223 834244
Wellcome Genome Campus,
Hinxton, Cambridgeshire, CB10 1SA. UK
+44 (0)1223 834244